Close
Terray Therapeutics has successfully raised $120 million in a Series B funding round aimed at enhancing its AI platform for small-molecule drug development. The funding was led by Bedford Ridge Capital and NVentures, the venture capital arm of Nvidia. This investment brings the total funding for Terray to over $200 million, highlighting the growing interest in AI applications within biotechnology.
The company focuses on small-molecule drugs, which are advantageous due to their low weight and ability to penetrate biological membranes. With the new funding, Terray plans to expand its generative AI model, tNova, and advance its internal immunology programs towards clinical trials. Collaborations with major pharmaceutical companies like Bristol Myers Squibb and Calico Life Sciences further emphasize the potential of AI in revolutionizing drug discovery.
• Terray Therapeutics raised $120 million for AI-driven drug development.
• The company aims to enhance its generative AI model, tNova.
Generative AI models like tNova are used to improve drug development speed and success rates.
Small-molecule drugs are favored for their predictability in dosing and ability to treat various diseases.
Terray has created the world's largest chemistry dataset, enhancing AI-driven drug discovery.
Terray Therapeutics utilizes AI to accelerate the development of small-molecule drugs.
Nvidia's venture arm, NVentures, is a key investor in Terray's funding round.
The Wall Street Journal 2month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
